The neurotoxicity of β-amyloid protein (AβP) is implicated in the etiology of Alzheimer's disease. We previously have demonstrated that AβP forms Ca 2+ -permeable pores on neuronal membranes, causes a marked increase in intracellular calcium level, and leads to neuronal death. Here, we investigated in detail the features of AβP-induced changes in intracellular Ca 2+ level in primary cultured rat hippocampal neurons using a multisite Ca 2+ -imaging system with fura-2 as a fl uorescent probe. Only a small fraction of short-term cultured hippocampal neurons (ca 1 week in vitro) exhibited changes in intracellular Ca 2+ level after AβP exposure. However, AβP caused an acute increase in intracellular Ca 2+ level in long-term cultured neurons (ca 1 month in vitro). The responses to AβP were highly heterogeneous, and immunohistochemical analysis using an antibody to AβP revealed that AβP is deposited on some but not all neurons. Considering that the disruption of Ca 2+ homeostasis is the primary event in AβP neurotoxicity, substances that protect neurons from an AβP-induced intracellular Ca 2+ level increase may be candidates as therapeutic drugs for Alzheimer's disease. In line with the search for such protective substances, we found that the preadministration of neurosteroids including dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone signifi cantly inhibits the increase in intracellular calcium level induced by AβP. Our results suggest the possible signifi cance of neurosteroids, whose levels are reduced in the elderly, in preventing AβP neurotoxicity.
Introduction
Alzheimer's disease (AD) is a senile type of dementia affecting many of the elderly. AD is pathologically characterized by selective neuronal loss, and the presence of numerous extracellular deposits termed senile plaques and intraneuronal neurofi brillary tangles (NFTs) in the patient's brain (Selkoe 1991) . The principal constituent of senile plaques is the β-amyloid protein (AβP), which is a peptide composed of 38-43 amino acids and a proteolytic product of a large precursor protein (amyloid precursor protein; APP). Genetic studies of early-onset cases of familial AD indicated that APP mutations and AβP metabolism are associated with the disease (Goate et al 1991) . Yankner and colleagues found that the segment comprising the fi rst 40 amino acid residues of AβP, termed AβP , has neurotoxic effects on primary cultured neurons of the rat hippocampus (Yankner et al 1990) . These lines of evidence support the idea that AβP and its neurotoxicity might be causal agents of neuronal death in AD patients (Small et al 2001) .
Although the molecular mechanism underlying AβP neurotoxicity is not yet fully understood, there are a growing number of studies suggesting that the disruption of Ca 2+ homeostasis is crucial to AβP neurodegeneration (Mattson et al 1992; Fraser et al 1997) . We previously showed that AβP is directly incorporated into membranes excised from GT1-7 cells, which are derived from the tumorigenesis of murine hypothalamic neurons, and forms unregulated cation-selective (including Ca 2+ ) ion channels (Kawahara et al 1997) . The characteristics of channels formed by AβP, ie, 'amyloid channels', on membranes of GT1-7 cells are similar to those of channels formed on artifi cial planar lipid membranes (Arispe et al 1993a (Arispe et al , 1993b (Arispe et al , 1996 . Other neurotoxic AβP fragments such as AβP [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] and AβP , and the C-terminal fragment peptide of APP termed CT 105 were also reported to form ion channels on artifi cial lipid bilayers or membranes of cultured neurons (Furukawa et al 1994; Mirzabecov et al 1994; Fraser et al 1996; Rhee et al 1998; Hirakura et al 1999) . Furthermore, we have demonstrated that AβP , AβP [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] and AβP (Kawahara 2004) . On the basis of these lines of evidences, we hypothesized that the ability of AβP to form unregulated 'amyloid channels' across neuronal membranes and the resulting disruption of calcium homeostasis explain the molecular mechanism of AβP neurotoxicity (Pollard et al 1995; Kawahara 2004 ). This mechanism of AβP neurotoxicity is similar to that of the toxicity of toxins, venoms, or the complement system (Tomita et al 1992; Bechinger 1997; Kobayashi et al 2004) .
Here, we applied AβP and/or AβP [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] to cultured hippocampal neurons and observed the spatiotemporal changes in [Ca 2+ ] i induced by AβP using a multisite Ca 2+ -imaging system with fura-2 as a fl uorescent probe. This system enables the simultaneous detection of temporal [Ca 2+ ] i changes in cultured neurons facilitating statistical analysis. In this study, we investigated in detail the features of AβP-induced [Ca 2+ ] i changes and observed heterogeneous cellto-cell responses to AβP in cultured hippocampal neurons. The localization of AβP to the plasma membrane regions of the neurons was also observed by laser confocal microscopy using immunohistochemistry after AβP exposure. Furthermore, we found that AβP caused an acute increase in [Ca 2+ ] i in many long-term cultured neurons. However, changes in intracellular Ca 2+ level after AβP exposure were rarely observed among the short-term cultured hippocampal neurons. Therefore, the difference in susceptibility to AβP among neurons cultured for different periods was also examined.
Thus, the search for substances that protect against AβP neurotoxicity is crucial. Our system for observing Ca 2+ infl ux induced by AβP has contributed to the search for such substances (Kawahara and Kuroda 2001) . It requires a relatively short time for carrying out assays. The elevation of [Ca 2+ ] i is considered to be the primary event of AβP neurotoxicity. We previously demonstrated that several lipophilic substances such as phloretin, cholesterol, and 17β-estradiol signifi cantly inhibit the AβP-induced elevation of [Ca 2+ ] i in GT1-7 cells (Kawahara and Kuroda 2001) . Phloretin, a plant-derived fl avonoid, decreases membrane potential and inhibits the electrostatic interaction between AβP and membrane lipids (Hertel et al 1997) . Cholesterol decreases membrane fl uidity and inhibits channel formation by peptides (Tomita et al 1992) . Cholesterol also blocks the increase in [Ca 2+ ] i induced by AβP in cultured neurons (Hartmann et al 1994) . 17β-estradiol, a female hormone, is neuroprotective and affects membrane fl uidity (Schwartz et al 1996) . All these compounds inhibit AβP neurotoxicity (Zhou and Richardson 1996; Hertel et al 1997; Olivieri et al 2002) . Therefore, substances that modulate membrane properties such as membrane potential and fl uidity may inhibit AβP neurotoxicity. In line with the search for neuroprotective agents, we focused on neurosteroids including dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S), and pregnenolone. These neurosteroids are steroid hormones synthesized de novo in the central nervous system from cholesterol or peripheral steroid precursors. Several lines of evidence suggest that neurosteroids modulate various functions of the brain and exhibit neuroprotective activities (Tsutsui et al 2000) . For example, DHEA-S could protect neurons from NMDA-induced neurotoxicity (Charalampopoulos et al 2006) . In addition, there is an age-related decrease in the levels of neurosteroids (Moffat et al 2000) , and the levels of neurosteroids in plasma or in the brain are decreased in Alzheimer's patients (Hillen et al 2000; Marx et al 2006) . Thus, neurosteroids have been recognized as anti-aging hormones, and are widely used as supplements for improving the impaired cognitive functions of the elderly (Huppert et al 2000) . (CA, USA). These peptides were dissolved in distilled water at 0.2 mM and stored at −80 °C. DHEA-S, DHEA, and pregnenolone were obtained from Sigma Ltd. (St. Louis, USA), and dissolved in dimethylsulfoxide (DMSO) at 10 mM.
Experimental procedures Chemicals and reagents

Cell culture
The hippocampus was dissected out from fetal rats (18-day embryonic stage) and neurons were cultured by the method of Banker and Cowan with slight modifi cations (Banker and Cowan 1977; Muramoto et al 1993) . Briefl y, after the removal of meninges, tissues were dissociated by mechanical trituration following digestion with 0.15 units/ml papain in phosphate-buffered saline (PBS) containing 0.02% L-cystein, 0.02% BSA, and 0.5% glucose. Dissociated neurons were placed on polyethylenimine-coated coverslips and cultured in Dulbecco's modifi ed Eagle's medium (DMEM) supplemented with 5% horse serum, 5% newborn calf serum, and 1 mM sodium pyruvate. The culture was maintained in a humidifi ed atmosphere of 93% air and 7% CO 2 at 37 ° C. After 3 days in vitro, the medium was replaced with serum-free DMEM supplemented with B27 (Gibco BRL, USA). The medium was changed every 3 days.
Intracellular free-calcium concentration measurements
The culture medium was replaced with a basal salt solution (BSS; in mM: 130 NaCl, 5.5 glucose, 5.4 KCl, 1.8 CaCl 2 , 20 sodium HEPES, pH 7.4) containing 1.5 mM fura-2 AM (acetoxymethylester cell-permeant form, Molecular Probes, Oregon, USA). The cultured neurons were incubated with fura-2 AM at 37 °C for 60 min, washed and replaced with BSS containing 1 µM TTX to inhibit the endogenous changes in [Ca 2+ ] i related to spontaneous synaptic fi rings (Robinson et al 1993) , and then observed under an inverted fl uorescence microscope (Nikon, Japan) equipped with a high-resolution video camera (C-2400, Hamamatsu Photonics Co., Japan). Fluorescence images correspond to [Ca 2+ ] i were recorded at a rate of 30 images/sec on VCR tapes and analyzed using an adhoc hardware and software system controlled by a computer (FC-300, Mitsubishi Kasei, Japan). Each image represents the fl uorescence intensity from a rectangular optical fi eld (360 × 420 mm 2 ), which enabled the monitoring of approximately 50 neurons simultaneously. The system enabled the recording of the ratio of the intensity emitted at 510 nm from pixels of images obtained by alternating the excitation wavelength between 340 and 360 nm using a rotating fi lter wheel. Each ratio was converted into [Ca 2+ ] i using a calibration curve (ratio versus [Ca 2+ ] i ).
As a rule, prior to AβP addition to the bath solution of the cells, we recorded the resting levels of neuronal [Ca 2+ ] i during a 5-min period. During the experiments, we added aliquots of the peptide stock solution directly to the bath solution (approximately 0.4 ml) of the cells. All recordings were obtained at 37 °C.
Immunohistochemistry
AβP[1-40] (2.5 µM) was applied onto hippocampal neurons cultured for 29 days in vitro (DIV). After 48 h, the cultured neurons were fi xed with 4% paraformaldehyde in Ca 2+ -and Mg 2+ -free PBS. After fi xation, the cultured neurons were incubated in PBS containing 0.5% saponin (Sigma Aldrich, St. Louis, USA) and 5% normal goat serum (Vector, UK) at 37 °C for 30 min to render the cell membranes permeable and to block nonspecifi c binding sites. The cultured neurons were incubated with primary antibodies diluted with 10% Block Ace (Dai-nihon Seiyaku, Japan) in PBS at 4 °C overnight. For double-immunofl uorescence staining, a combination of a mouse monoclonal antibody and a rabbit polyclonal antibody was added to the cell preparation. An anti-microtubule associated protein 2 (MAP2) antibody (1:500, monoclonal, obtained from Boehringer Mannheim, Darmstadt, Germany) and an anti-AβP antibody (1:100, polyclonal, anti-N terminus of human AβP , obtained from IBL, Tokyo, Japan) were used as primary antibodies. Thereafter, the cells were incubated with anti-mouse Ig, biotinylated species-specifi c whole antibody (1:500, Amersham Pharmacia Biotech Ltd., Buckinghampshire, England), and then with an FITC-conjugated goat anti-rabbit IgG antibody (1:500, Cappel) and Texas red-conjugated streptavidin (1:500, Bio-Rad Laboratories, California, USA). Stained cells were observed under a confocal laser scanning microscope (LSM 510; Zeiss).
Pretreatment with neurosteroids
Prior to the 20-30 min exposure to AβP, the solutions of DHEA-S, DHEA, and pregnenolone were diluted with BSS and were added to the bath solution of the neurons. Thereafter, we carried out the same protocol designed to test the effects of AβP. As a control, 0.5% DMSO was applied to the cultured neurons, followed by 20 µM AβP [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] .
Statistical analyses
Our system enabled the accurate measurement of the amplitude of the peak [Ca 2+ ] i increase (∆ [Ca 2+ ] i ) in the response. To construct histograms from these data, we grouped the cell responses in bins (bin width, 20 nM) and then plotted the number of cells/bin as a function of peak [Ca 2+ ] i . We obtained both the mean amplitude of the early peak [Ca 2+ ] i for each neuron and the mean percentage of cells responding to AβP. Data are expressed as means ± standard error of mean (SEM) of 25 to 50 neurons in one optical fi eld. All statistical evaluations were carried out using a two-tailed Student's ttest using Stat View (SAS Institute, NC, USA). A probability level of Ͻ0.05 was considered to be signifi cant. ] i to 311 ± 37 nM (mean ± SEM, n = 250) in 79 ± 3% (mean ± SEM, n = 5) of neurons in the same optical fi eld.
Results
Effects
Heterogeneity of cell-to-cell responses to AβP
Further detailed analysis of the elevation of [Ca 2+ ] i in many neurons in the same optical fi eld revealed that the type of response of one neuron to AβP was not identical to that of another neuron and that not all neurons exhibited [Ca 2+ ] i increase after the AβP addition. As shown in Figure 1A (b) , the cell-to-cell responses to AβP were highly heterogeneous among neighboring neurons. The variability in neuronal responses is similar to our previous work using genetically identical GT1-7 cells, which exhibit heterogeneous responses after their exposure to AβP [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] Fig. 2A ] i within 5 min after the AβP[1-40] exposure (eg, cell nos. 6, 9, 10, 12, and 20 in Figure 2A ), whereas [Ca 2+ ] i in other neurons remained high at least 5 min after the exposure (cell nos. 2, 7, and 16). The delayed elevation of [Ca 2+ ] i after the AβP exposure was observed in cell nos. 13, 15, 17, and 18. We observed no detectable elevation of [Ca 2+ ] i in neighboring neurons (eg, cell nos. 4 and 14) .
Furthermore, we applied AβP[1-40] at a sublethal level (2.5 µM) to cultured hippocampal neurons and observed AβP binding to membrane surfaces. Cultured neurons were fi xed and double-immunostained using antibodies to AβP and MAP2, a neuronal marker. Fluorescence images were observed under a laser confocal microscope. Figure 2B shows that the affi nities of AβP to neuronal membrane surfaces are also highly heterogeneous. AβP was found to deposit on somata and dendrites in some neurons (labeled by asterisks in Figures 2B (a) and (d)) ; however, we found no detectable AβP[1-40] deposition on surfaces of neighboring neurons. Note that the morphological characteristics of these neurons were similar. Figures 2B (d) -(f) show highermagnifi cation images of the same area shown in Figures 2B  (a)-(c) . The AβP binding to neurons (asterisks) is not homogeneous. Moreover, AβP localizes to restricted areas of the somata and dendrites ( Figure 2B (e) ), whereas MAP2 is homogeneously distributed (Figure 2B (d) ). ] i in cultured neurons pretreated with DHEA, DHEA-S, or pregnenolone were 50 ± 9.2%, 0.7 ± 0.5%, 13 ± 4% that of the control (neurons pretreated with 0.5 % DMSO), respectively (mean ± SEM, n = 200) ( Figure 3A) . The percentages of neurons responding to AβP among those pretreated with DHEA, DHEA-S, and pregnenolone also decreased ( Figure 3B) .
Protection against AβP-induced [Ca
The inhibition by DHEA-S was more marked than those by DHEA or pregnenolone. Figure 4A shows typical responses to AβP [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (20 µM) with (b) or without (a) DHEA-S pretreatment (10 µM) in the same view fi eld. Figure  4B shows the histograms constructed from measurements of the peak [Ca 2+ ] i increase in each neuron. Figures 4C and 4D show the dose-dependent effects of DHEA-S on the mean increase in [Ca 2+ ] i and the percentage of responding neurons induced by AβP [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , respectively. DHEA-S at 1 and 10 µM inhibited the mean [Ca 2+ ] i changes to 58 ± 15% and 35 ± 7% that of control (pretreated with 0.5% DMSO) neurons, respectively (mean ± SEM, n = 250). In the case of using DHEA-S at more than 25 µM, most neurons exhibited no signifi cant increase in [Ca 2+ ] i . 
Discussion
We observed the spatiotemporal changes in [Ca 2+ ] i in cultured rat hippocampal neurons induced by AβP [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] and AβP , both exhibiting β-sheet formation and neurotoxicity. Our results indicate that long-term (ca 1 month) cultured neurons are more susceptible to AβP than short-term (ca 1 week) cultured neurons. We have also demonstrated that the responses to AβP [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] as well as to AβP are highly heterogeneous among neighboring cultured neurons and that AβP has an affi nity to some type of neuron. Our results are in accordance with the previous results showing that induces changes in electrophysiological activities in 3-to 4-week-cultured rat cerebral cortical neurons (Hartley et al 1999) . Although factors affecting the susceptibility of neurons to AβP are under investigation, it is widely accepted that the properties of membrane lipids including membrane fl uidity and the net charge of membrane surfaces are crucial to peptide binding and the subsequent channel formation (Terzi et al 1994) . In particular, the changes in membrane properties such as the level ratio of cholesterol to other phopholipids during the in vitro development of cultured hippocampal neurons may be important. In particular, cholesterol decreases membrane fl uidity and thus inhibits the assembly of peptides (Fujii et al 1997) . The addition of cholesterol to membrane lipids inhibits the formation of ion channels by prion fragment peptides (Mirzabekov 1994) or Staphylococcus aureus α-toxin (Tomita et al 1992) . Numerous epidemiological studies have suggested that a genotype of apolipoprotein E (E4 allele), which plays important roles in the transfer and metabolism of cholesterol, is a risk factor for AD (Corder et al 1993) and that cholesterol is signifi cant in AD pathology (Hartmann 2001) . Cholesterol has been reported to block the elevation of [Ca 2+ ] i induced by AβP (Hartmann et al 1994; , inhibit AβP neurotoxicity (Zhou and Richardson 1996) , and affect the secretion of AβP (Frears et al 1999) . It is also possible that the percentage of neurons that are resistant to AβP neurotoxicity changes during in vitro development. In particular, gamma-aminobutyric acid (GABA)-immunopositive neurons may be important in the developmental change in susceptibility to AβP because of their resistance to AβP neurotoxicity (Pike and Cotman 1993) . We have demonstrated that the developmental changes of GABAergic synapses occur at 7-14 DIV (Kato-Negishi et al 2004) .
The search for protective agents against AβP neurotoxicity is of great importance. Our system for observing Ca 2+ infl ux through AβP channels has contributed to the search for such substances (Kawahara and Kuroda 2001) . In line with the search for protective agents, we found that neurosteroids including DHEA, DHEA-S, and pregnenolone signifi cantly inhibit the [Ca 2+ ] i elevation induced by AβP. DHEA and DHEA-S have neuroprotective effects against excitotoxicity (Kimonides et al 1998) . Considering that plasma DHEA-S level is reduced in healthy individuals in an age-dependent manner and in AD patients (Hillen et al 2000) , the implication of DHEA-S in the pathogenesis of AD may be important. Although the mechanism that DHEA-S inhibits AβP-induced elevation of [Ca 2+ ] i is still under investigation, it is possible that DHEA-S modulates membrane fl uidity or membrane potential, and infl uences the affi nity of AβP to membranes. Further research about the infl uences of DHEA-S on the AβP binding to membrane surfaces is necessary. Moreover, it is interesting that DHEA-S can modulate GABA receptors (Meyer et al 1999) . Further studies of the mechanism underlying the differences in AβP susceptibility and the mechanism of inhibition by neurosteroids are necessary to confi rm the above possibilities. Our results are the fi rst to suggest the role of neurosteroids in AβP neurotoxicity and the development of neurosteroids for AD treatment. In conclusion, our results may aid in improving our understanding of AD and the development of drugs for AD treatment.
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